Eupraxia Pharmaceuticals Inc. (EPRX): who owns it and who trades it
As of Nov 16, 2026, no open-market insider purchases or sales of EPRX were reported in the last 12 months. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Eupraxia Pharmaceuticals
From the latest filingsOverall: about as much buying as selling. Funds mostly bought. Famous investors was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns EPRX
68 funds and institutions reported EPRX shares worth $164M at the end of Q2 2026, about 70% of the company. The largest holder is Beutel, Goodman & Co Ltd. with 10.2%.
Funds and institutions (13F) 70%Everyone else 30%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Beutel, Goodman & Co Ltd. | 3.63M | 10.18% | $23.8M | -1% |
| Affinity Asset Advisors, LLC | 1.65M | 4.63% | $10.9M | +4% |
| Balyasny Asset Management L.P. | 1.35M | 3.79% | $8.9M | No change |
| Vivo Capital, LLC | 1.35M | 3.79% | $8.9M | No change |
| Scotia Capital Inc. | 1.34M | 3.77% | $8.8M | +0% |
| PFM Health Sciences, LP | 1.21M | 3.40% | $8M | +124% |
| Great Point Partners LLC | 1.20M | 3.37% | $7.9M | No change |
| Jupiter Topco LLC | 1.05M | 2.93% | $6.9M | New |
| Rubric Capital Management LP | 867,424 | 2.43% | $5.7M | +26% |
| Ikarian Capital, LLC | 809,741 | 2.27% | $5.4M | -33% |
| Woodline Partners LP | 746,864 | 2.10% | $4.9M | +70% |
| Point72 Asset Management, L.P. | 730,284 | 2.05% | $4.8M | -25% |
| Ameriprise Financial Inc | 711,024 | 1.99% | $4.7M | +36% |
| Redmile Group, LLC | 611,400 | 1.72% | $4M | -13% |
| Seven Fleet Capital Management LP | 610,785 | 1.71% | $4M | +41% |
| UBS Group AG | 519,211 | 1.46% | $3.4M | -32% |
| Citadel Advisors LLC | 502,011 | 1.41% | $3.3M | +118% |
| Millennium Management LLC | 441,586 | 1.24% | $2.9M | New |
| Alyeska Investment Group, L.P. | 375,000 | 1.05% | $2.5M | No change |
| Picton Mahoney Asset Management | 360,878 | 1.01% | $2.4M | New |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
No EPRX insider reported an open-market purchase or sale in the last 12 months.
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
EPRX short interest
6.25M EPRX shares are sold short. Over the last 12 reports the number of shares short went up 75%.
As of Oct 30, 2026, 6.25M EPRX shares were sold short, down 4.5% from the report before. At the average daily volume of 602,929 shares, buying them all back would take about 10.4 trading days (days to cover).
Shares short
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 6.25M | – | -4% | 602,929 | 10.4 |
| Oct 15, 2026 | 6.54M | – | -4% | 1.25M | 5.2 |
| Sep 30, 2026 | 6.80M | – | -10% | 614,408 | 11.1 |
| Sep 15, 2026 | 7.58M | – | +7% | 673,955 | 11.2 |
| Aug 31, 2026 | 7.11M | – | +12% | 385,471 | 18.4 |
| Aug 14, 2026 | 6.34M | – | +5% | 220,310 | 28.8 |
| Jul 31, 2026 | 6.04M | – | +2% | 465,259 | 13.0 |
| Jul 15, 2026 | 5.92M | – | +8% | 230,018 | 25.7 |
| Jun 30, 2026 | 5.46M | – | +19% | 607,348 | 9.0 |
| Jun 15, 2026 | 4.60M | – | +13% | 282,503 | 16.3 |
| May 29, 2026 | 4.08M | – | +15% | 332,600 | 12.3 |
| May 15, 2026 | 3.56M | – | +16% | 149,950 | 23.8 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Eupraxia Pharmaceuticals financials
Famous investors that hold EPRX
2 of the 50 well-known investors we track reported holding EPRX in their latest 13F filing. The largest position is Ken Griffin's, worth $8.9M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 978,875 | $8.9M | 0.0% | +95% |
| Israel Englander · Millennium Management | Q3 2026 | 105,436 | $961K | 0.0% | -76% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Eupraxia Pharmaceuticals Inc. (EPRX) stock
Who owns the most EPRX stock?
The largest reported owner of Eupraxia Pharmaceuticals Inc. (EPRX) is Beutel, Goodman & Co Ltd., with 10.2% of the company. In total, 68 funds and institutions reported holding EPRX at the end of Q2 2026, together about 70% of the shares. See the largest owners.
Are EPRX insiders buying or selling?
No EPRX insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.
What is the short interest in EPRX?
As of Oct 30, 2026, 6.25M EPRX shares were sold short, down 4.5% from the report before. At the average daily volume of 602,929 shares, buying them all back would take about 10.4 trading days (days to cover). See the history.
Which famous investors hold EPRX?
2 of the 50 well-known investors we track reported EPRX in their latest 13F filing, including Ken Griffin, Israel Englander. The largest position is worth $8.9M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.